[{"address1": "700 Quince Orchard Road", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 268 2000", "website": "https://www.novavax.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 952, "companyOfficers": [{"maxAge": 1, "name": "Mr. John Charles Jacobs M.B.A.", "age": 57, "title": "President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 1550611, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James Patrick Kelly C.F.A.", "age": 58, "title": "Executive VP, CFO & Treasurer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 880849, "exercisedValue": 0, "unexercisedValue": 19825}, {"maxAge": 1, "name": "Mr. Mark J. Casey Esq.", "age": 61, "title": "Executive VP, Chief Legal Officer & Corporate Secretary", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 997654, "exercisedValue": 0, "unexercisedValue": 89347}, {"maxAge": 1, "name": "Ms. Elaine  O'Hara", "age": 56, "title": "Executive VP & Chief Strategy Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 991316, "exercisedValue": 0, "unexercisedValue": 35053}, {"maxAge": 1, "name": "Mr. Richard P. Crowley", "age": 67, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Troy  Morgan Esq., J.D.", "age": 53, "title": "Senior VP, Deputy General Counsel & Chief Compliance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erika S. Trahan", "title": "Associate Director of Investor & Public Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ian J. Watkins", "age": 61, "title": "Executive VP & Chief Human Resources Officer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Silvia  Taylor M.B.A.", "title": "Executive VP, Chief Corporate Affairs Officer & Head of Novavax Sweden", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Henrietta  Ukwu FACP FRAPS, M.D.", "age": 57, "title": "Executive VP & Chief Regulatory Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 5, "compensationRisk": 6, "shareHolderRightsRisk": 5, "overallRisk": 5, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.novavax.com/go.cfm?do=Stock.GetQuote", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.22, "open": 6.25, "dayLow": 6.245, "dayHigh": 6.54, "regularMarketPreviousClose": 6.22, "regularMarketOpen": 6.25, "regularMarketDayLow": 6.245, "regularMarketDayHigh": 6.54, "payoutRatio": 0.0, "beta": 2.295, "trailingPE": 3.2189054, "forwardPE": -40.4375, "volume": 4037550, "regularMarketVolume": 4037550, "averageVolume": 4840017, "averageVolume10days": 4967120, "averageDailyVolume10Day": 4967120, "bid": 4.7, "ask": 8.02, "bidSize": 2, "askSize": 2, "marketCap": 1051368448, "fiftyTwoWeekLow": 5.01, "fiftyTwoWeekHigh": 11.55, "allTimeHigh": 331.68, "allTimeLow": 3.53, "priceToSalesTrailing12Months": 0.98752403, "fiftyDayAverage": 8.2238, "twoHundredDayAverage": 7.4924, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 539614528, "profitMargins": 0.32099, "floatShares": 134905041, "sharesOutstanding": 162498995, "sharesShort": 48322992, "sharesShortPriorMonth": 43445298, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.2974, "heldPercentInsiders": 0.087510005, "heldPercentInstitutions": 0.60867, "shortRatio": 11.05, "shortPercentOfFloat": 0.2985, "impliedSharesOutstanding": 162498995, "bookValue": -0.964, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": 341744992, "trailingEps": 2.01, "forwardEps": -0.16, "lastSplitFactor": "1:20", "lastSplitDate": 1557446400, "enterpriseToRevenue": 0.507, "enterpriseToEbitda": 1.194, "52WeekChange": -0.332618, "SandP52WeekChange": 0.09209216, "quoteType": "EQUITY", "currentPrice": 6.47, "targetHighPrice": 25.0, "targetLowPrice": 6.0, "targetMeanPrice": 12.66667, "targetMedianPrice": 11.0, "recommendationMean": 2.33333, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 762894016, "totalCashPerShare": 4.695, "ebitda": 451828000, "totalDebt": 251140000, "quickRatio": 1.854, "currentRatio": 2.267, "totalRevenue": 1064651008, "revenuePerShare": 6.595, "returnOnAssets": 0.18014, "grossProfits": 632619008, "freeCashflow": -455231136, "operatingCashflow": -378323008, "revenueGrowth": -0.166, "grossMargins": 0.59419996, "ebitdaMargins": 0.42439, "operatingMargins": -1.12684, "financialCurrency": "USD", "symbol": "NVAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 818173800000, "postMarketChangePercent": 0.4636818, "postMarketPrice": 6.5, "postMarketChange": 0.03000021, "regularMarketChange": 0.25, "regularMarketDayRange": "6.245 - 6.54", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 4840017, "fiftyTwoWeekLowChange": 1.4599996, "fiftyTwoWeekLowChangePercent": 0.29141706, "fiftyTwoWeekRange": "5.01 - 11.55", "fiftyTwoWeekHighChange": -5.0800004, "fiftyTwoWeekHighChangePercent": -0.43982688, "fiftyTwoWeekChangePercent": -33.2618, "dividendDate": 1557446400, "earningsTimestamp": 1762435800, "earningsTimestampStart": 1762435800, "earningsTimestampEnd": 1762435800, "earningsCallTimestampStart": 1762435800, "earningsCallTimestampEnd": 1762435800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 2.01, "epsForward": -0.16, "epsCurrentYear": 2.03587, "priceEpsCurrentYear": 3.1780024, "shortName": "Novavax, Inc.", "regularMarketChangePercent": 4.01929, "regularMarketPrice": 6.47, "corporateActions": [], "postMarketTime": 1763773172, "regularMarketTime": 1763758801, "exchange": "NMS", "messageBoardId": "finmb_350381", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -1.7537999, "fiftyDayAverageChangePercent": -0.21325907, "twoHundredDayAverageChange": -1.0224004, "twoHundredDayAverageChangePercent": -0.13645832, "priceToBook": -6.711618, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "longName": "Novavax, Inc.", "displayName": "Novavax", "trailingPegRatio": null, "__fetch_time": "2025-11-22"}]